1. Small Esophageal Varices in Patients with Cirrhosis—Should We Treat Them?

   • Thomas Reiberger
   • Theresa Bucsics
   • Mattias Mandorfer

   Portal Hypertension (J Gonzalez-Abraldes and E Tsochatzis, Section Editors) Open access 07 November 2018 Pages: 301 - 315

   

2. Portal Cavernoma Cholangiopathy

   • Dominique-Charles Valla

   Portal Hypertension (J Gonzalez-Abraldes and E Tsochatzis, Section Editors) 05 October 2018 Pages: 316 - 323

   

3. The Role of Radiologic Modalities in Diagnosing Nonalcoholic Steatohepatitis (NASH) and Fibrosis

   • Ralf Weiskirchen
   • Frank Tacke

   Fatty Liver Disease (Z Younossi, Section Editor) 19 September 2018 Pages: 324 - 335

   

4. The Impact of Metabolic Syndrome on the Outcome of NASH: Cirrhosis, Hepatocellular Carcinoma, and Mortality

   • Ramy Younes
   • Elisabetta Bugianesi

   Fatty Liver Disease (Z Younossi, Section Editor) 26 September 2018 Pages: 336 - 344

5. The Clinical and Economic Burden of Nonalcoholic Steatohepatitis

   • Brian Lam
   • Kyle Kurzke
   • Zobair Younossi

   Fatty Liver Disease (Z Younossi, Section Editor) 19 September 2018 Pages: 345 - 349

6. Pathogenesis of NASH: the Impact of Multiple Pathways

   • Mazen Noureddin
   • Arun J. Sanyal

   Fatty Liver Disease (Z Younossi, Section Editor) 31 October 2018 Pages: 350 - 360

   

7. Update on Pediatric Fatty Liver Disease

   • Sylvia Doan
   • Barbara J. Niklinska-Schirtz
   • Miriam B. Vos

   Fatty Liver Disease (Z Younossi, Section Editor) 17 October 2018 Pages: 361 - 366

8. Surgical Issues in NASH: Bariatric Surgery and Liver Transplantation

   • Sonali Paul
   • Michael Charlton

   Fatty Liver Disease (Z Younossi, Section Editor) 21 November 2018 Pages: 367 - 376

   

9. The Impact of Direct-acting Antiviral Therapy for Hepatitis C on Hepatocellular Carcinoma Risk

   • Feng Su
   • George N. Ioannou

   Hepatic Cancer (A Singal and A Mufti, Section Editors) 20 September 2018 Pages: 377 - 384

   

10. Management of Combined Hepatocellular Carcinoma-Cholangiocarcinoma

    • Ju Dong Yang
    • Lewis R. Roberts

    Hepatic Cancer (A Singal and A Mufti, Section Editors) 17 October 2018 Pages: 385 - 391

    

11. Stereotactic Ablative Radiotherapy (SABR/SBRT) for Hepatocellular Carcinoma

    • Byung-Han Rhieu
    • Amol K. Narang
    • Jeffrey Meyer

    Hepatic Cancer (A Singal and A Mufti, Section Editors) Open access 16 October 2018 Pages: 392 - 398

12. Indications and Best Practices for Intra-arterial Therapies to Treat Hepatocellular Carcinoma

    • Michael Hsu
    • Muneeb Ahmed
    • Ammar Sarwar

    Hepatic Cancer (A Singal and A Mufti, Section Editors) 10 October 2018 Pages: 399 - 411

    

13. Primary Liver Tumors Other than Hepatocellular Carcinoma: Clinical and Molecular Pearls

    • Antonio Costantino Jr
    • Tamar H. Taddei

    Hepatic Cancer (A Singal and A Mufti, Section Editors) 02 October 2018 Pages: 412 - 424

14. LI-RADS v2018: a Primer and Update for Clinicians

    • Kathryn J. Fowler
    • Elizabeth Hecht
    • Claude B. Sirlin

    Hepatic Cancer (A Singal and A Mufti, Section Editors) 24 October 2018 Pages: 425 - 433

    

15. Current State of Immunotherapy for HCC—Supporting Data and Toxicity Management

    • Anthony Bejjani
    • Richard S. Finn

    Hepatic Cancer (A Singal and A Mufti, Section Editors) 28 October 2018 Pages: 434 - 443

    

16. Hepatitis B Reactivation in the DAA Era: Minding the Gap Between the Black Box and Clinical Practice

    • Ann T. Ma
    • Jordan J. Feld

    Hepatitis B (J Lim, Section Editor) 17 October 2018 Pages: 444 - 450

    

17. Implications of Circulating Hepatitis B Virus RNA Levels in Assessment of Response to Antiviral Therapy

    • Tianlun Zhou
    • Chuanmin Wang
    • Timothy Block

    Hepatitis B (J Lim, Section Editor) 18 October 2018 Pages: 451 - 458

    

18. Impact of Chronic Hepatitis B Infection on Patient-Reported Outcomes

    • Rakesh Biswas
    • Pegah Golabi
    • Zobair M. Younossi

    Hepatitis B (J Lim, Section Editor) 15 October 2018 Pages: 459 - 465

    

19. New Advances in Hepatitis B Vaccination for Adults

    • Qingyao Daniel Huang
    • Seng-Gee Lim

    Hepatitis B (J Lim, Section Editor) 08 October 2018 Pages: 466 - 474

20. Update in the Management of Chronic Hepatitis B in Pregnancy

    • Kalyan Ram Bhamidimarri
    • Calvin Q. Pan

    Hepatitis B (J Lim, Section Editor) 08 November 2018 Pages: 475 - 484

21. Prevention and Management of HBV Infection in Patients with Chronic Kidney Disease Requiring Renal Transplantation

    • Andres F. Carrion
    • Paul Martin

    Hepatitis B (J Lim, Section Editor) 13 October 2018 Pages: 485 - 491

22. Non-invasive Fibrosis Testing in Patients with Chronic Hepatitis B

    • Clément Lejealle
    • Laurent Castera

    Hepatitis B (J Lim, Section Editor) 15 October 2018 Pages: 492 - 501

23. Long-term Outcomes in Patients with HBV Treated with Antiviral Agents

    • Mauro Viganò
    • Alessandro Loglio
    • Pietro Lampertico

    Hepatitis B (J Lim, Section Editor) 05 November 2018 Pages: 502 - 510

    

24. Correction: The Role of Anticoagulation in Treating Portal Hypertension

    • Laura Turco
    • Filippo Schepis
    • Erica Villa

    Correction Open access 16 November 2018 Pages: 511 - 511